江苏恒盛药业有限公司怎么样?
COME BUY ??兰先生
2024-05-24 21:02:05
最佳回答
简介:江苏恒盛药业有限公司系江苏高科技股份制企业,投资方为(1)上海主板一上市公司及(2)南京一大型投资公司等,拥有精通国际国内医药业务的国际化及本土化的管理团队,现有员工300余人,并快速增长发展转型中。公司现有业务年销售额近3亿元,正实施新型生物医药投资项目,并推进综合制药采购、技术、cgmp制造、准入法规及国内外市场的一体化原料药和制剂的具备国际水准的业务转型,对呼吸道疾病及代谢性疾病治疗药品的业务进行创新及价值整合。业务范围包含苏州张家港市扬子江国际工业园区的制造及研发放大基地,上海徐汇区聚科高科技园区的商务研发中心,以及正并购中的其它医药业务。 jiangsu hansyn pharmaceutical co., ltd ** a high-tech private pharmaceutical organization in jiangsu, with share holders of (1) a shanghai stock exchange l**ted company, (2) a fund-management & investment company in nanjing, and others. its assets include a manufacturing site in zhangjiagang international industrial park, and a r&d and business center in juke high-tech park in xuhui d**trict, shanghai. it owns a core management team from both overseas returnees and local talents in pharmaceutical industry, with a staff of over 300 currently and under rapid expansion. its ex**ting revenue ** about rmb 300m, with new investments of manufacturing + r&d for active pharmaceutical ingredients ** being executed, and possible acqu**itions ongoing. the business focus ** to provide the optimum integrated services and products for regulated sourcing, contract research & development (cro) and cgmp custom manufacturing (cmo) to pharmaceutical industry. with its experience and expert**e in pharmaceutical and chem**try, the company ** striving to offer value synergies and innovations to customers via sustainable partnership in key therapeutic areas including respiratory, metabol**m and diabetes.法定代表人:朱郁健成立日期:2002-09-29注册资本:10000万元人民币所属地区:江苏省统一社会信用代码:91320592743110235l经营状态:在业所属行业:制造业公司类型:有限责任公司人员规模:100-499人企业地址:江苏扬子江国际化工园长江路东、黄海路南经营范围:生产兽药(限按许可证所列项目经营),生产对甲砜基苯丝氨酸**,生产医药中间体(雄甾羟基酸、雄甾硫代羧酸、雄甾硫代羧酸丙酸酯、苄已胺双羟苯乙酮富马酸盐、已胺双羟苯乙酮、吲哚乙烯**、**甲腈、氨基吡嗪酰胺、乙酰基神经氨酸甲酯、氨基脱水神经氨酸、氯喹啉**、氯喹啉**甲磺酸酯、氯喹啉环丙乙酸、双羟氮杂环丁酮、醛基氮杂环丁酮、氟**氮杂环丁酮),**(危险化学品除外)的购销,自营和代理各类商品或货物的进出口业务(**限定公司经营或禁止进出口的商品除外),医药原料药(萘普生、扎那米韦、孟鲁司特钠、罗格列酮、依折麦布、氟替卡松丙酸酯、沙美特罗羟基萘甲酸盐、那拉曲坦、硫酸沙丁胺醇、维格列汀、西格列汀、l-丙氨酸)的研发中试,医药、生物、化学专业领域内的技术开发、技术咨询、技术服务、技术转让。(依法须经批准的项目,经相关部门批准后方可开展经营活动) 20210311